OTC: LYPHF - Luye Pharma Group Ltd.

Yield per half year: -19.89%
Sector: Healthcare

Current price
0.3094 $
Average price
0.2199 $ -28.92%

Price based on EPS
0.4007 $ +29.52%
5/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 0.4007 $
Current price = 0.3094 $ (difference = +29.52%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 4.76 $
Current price = 0.3094 $ (difference = +1 437.27%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 3.08 $
Current price = 0.3094 $ (difference = +896.64%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription